Health & Environmental Research Online (HERO)


Print Feedback Export to File
2720217 
Journal Article 
Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia 
Toms, LML; Calafat, AM; Kato, K; Thompson, J; Harden, F; Hobson, P; Sjödin, A; Mueller, JF 
2009 
Environmental Science & Technology
ISSN: 0013-936X
EISSN: 1520-5851 
AMER CHEMICAL SOC 
WASHINGTON 
43 
11 
4194-4199 
English 
Polyfluoroalkyl chemicals (PFCs) have been used worldwide for more than 50 years in a wide variety of industrial and consumer products. Limited data exist on human exposure to PFCs in the Southern Hemisphere. Human blood serum collected in southeast Queensland, Australia, in 2006−2007 from 2420 donors was pooled according to age (cord blood, 0−0.5, 0.6−1, 1.1−1.5, 1.6−2, 2.1−2.5, 2.6−3, 3.1−3.5, 3.6−4, 4.1−6, 6.1−9, 9.1−12, 12.1−15, 16−30, 31−45, 46−60, and >60 years) and gender and was analyzed for eight PFCs. Across all pools, perfluorooctane sulfonate (PFOS) was detected at the highest mean concentration (15.2 ng/mL) followed by perfluorooctanoate (PFOA, 6.4 ng/mL), perfluorohexane sulfonate (PFHxS, 3.1 ng/mL), perfluorononanoate (PFNA, 0.8 ng/mL), 2-(N-methyl-perfluorooctance sulfonamide) acetate (Me-PFOSA-AcOH, 0.66 ng/mL), and perfluorodecanoate (PFDeA, 0.29 ng/mL). Perfluorooctane sulfonamide was detected in only 24% of the pools, and 2-(N-ethylperfluorooctane sulfonamide) acetate was detected in only one. PFOS concentrations were significantly higher in pools from adult males than from adult females (p = 0.002); no gender differences were apparent in the pools from children (<12 years old). The highest mean concentrations of PFOA, PFHxS, PFNA, PFDeA, and Me-PFOSA-AcOH were found in children <15 years, while PFOS was highest in adults >60 years. Investigation into the sources and exposure pathways in Australia, in particular for children, is necessary as well as continued biomonitoring to determine the potential effects on human concentrations as a result of changes in the PFC manufacturing practices, including the cessation of production of several PFCs. 
Health & Safety Science Abstracts; Environment Abstracts; Pollution Abstracts; Consumer products; sulfonates; Bioindicators; Infants; Children; Australia, Queensland; Chemicals; ENA 02:Toxicology & Environmental Safety; H 6000:Natural Disasters/Civil Defense/Emergency Management; P 6000:TOXICOLOGY AND HEALTH 
PFAS
• 5:3 acid
     Literature Search
          WOS
     Screening Results
          Excluded/Not on Topic
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          PubMed
          Web of Science
          ToxNet
          Other Sources
               Reference list review of included studies
     Screened Studies
          Supplemental
     2-(N-Methylperfluorooctanesulfonamido)acetic acid
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
     Screened Studies
          Excluded
               Exclude (TIAB)
     Perfluorooctane
     2-(N-Methylperfluorooctanesulfonamido)acetic acid
• NMeFOSAA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Susceptible populations
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFDA (335-76-2)
          Literature Search
               Pubmed
               WOS
     PFNA (375-95-1)
          Literature Search
               Pubmed
               WOS
     PFHxS (355-46-4)
          Literature search
               Pubmed
               WOS
     PFOSA (754-91-6)
          Literature Search
               Pubmed
               WOS
     NMeFOSAA (2355-31-9)
          Literature Search
               Pubmed
               WOS
     5:3 acid (914637-49-3)
          Literature Search
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
     Screened Studies
          Supplemental
     Perfluorinated compounds
     Perfluorohexanesulfonic acid
     Perfluorononanoic acid
     Perfluorooctane
     Perfluorooctanesulfonamide
     Perfluorooctanesulfonic acid
• PFDA
     Literature Search
          Pubmed
          WOS
     Scopus: April 2021
     Screening Results
          Susceptible populations
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               Exposure assessment or qualitative exposure only
     Literature Searches (through April 2023 update and post-public comment/peer review)a    
          Title & Abstract Screening
               Tagged as Supplemental
                    Full Text Screening
                    Exposure assessment or qualitative exposure only
• PFHxS
     Database searches
          Pubmed
          Toxline
          WOS
          Scopus
     Inclusion
          TiAb
     Supplemental
          Full Text
• PFNA
     Literature Search (August 2017)
          Pubmed
     PFNA Literature Search pre-2019
          Pubmed
          WOS
     Literature Search
          Pubmed
          WOS
     Screening Results
          Susceptible populations
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               Exposure assessment or qualitative exposure only
• PFOSA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Susceptible populations